Platelet Transfusion
Publication Date: November 28, 2017
Key Points
Key Points
Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Treatment
Treatmen...
...aration of Platelet ProductsPlatelets f...
...ention of Rh AlloimmunizationUPDATED. Prevention...
...uctionUPDATED. The incidence of alloantib...
...hylactic vs Therapeutic Platelet Transfu...
...telet Transfusion Threshold in Patients with Hema...
...sfusion Threshold in the Setting of...
...telet Transfusion in Patients with Chronic,...
...Transfusion Threshold in Patients With Solid...
...t at which Surgical or Invasive Procedures May Be...
...oring for Refractoriness to Platelet TransfusionU...
Managing Refractoriness to Platelet Transfusio...